HUP0101081A2 - Medium and method for viral propagation and growth - Google Patents
Medium and method for viral propagation and growthInfo
- Publication number
- HUP0101081A2 HUP0101081A2 HU0101081A HUP0101081A HUP0101081A2 HU P0101081 A2 HUP0101081 A2 HU P0101081A2 HU 0101081 A HU0101081 A HU 0101081A HU P0101081 A HUP0101081 A HU P0101081A HU P0101081 A2 HUP0101081 A2 HU P0101081A2
- Authority
- HU
- Hungary
- Prior art keywords
- medium
- growth
- viral propagation
- propagation
- proteins
- Prior art date
Links
- 230000003612 virological effect Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 239000000419 plant extract Substances 0.000 abstract 2
- 235000021120 animal protein Nutrition 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
A találmány tárgyát tápközeg és eljárás képezi tenyésztett sejtekenvégrehajtott vírustenyésztésre és vírusszaporításra. A találmányszerinti tápközeg humán vagy állati proteinektől - még rekombinánseredetű proteinektől is - mentes, és növényi extraktumokat vagynövényi extraktum hidrolizátumokat tartalmaz. A találmány szerintitápközeg és eljárás alkalmas vakcinák előállítására. ÓThe subject of the invention is a culture medium and a method for virus cultivation and propagation of viruses performed on cultured cells. The medium according to the invention is free of human or animal proteins - even proteins of recombinant origin - and contains plant extracts or plant extract hydrolysates. The nutrient medium and method according to the invention are suitable for the production of vaccines. HE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803333A FR2775983B1 (en) | 1998-03-13 | 1998-03-13 | VIRAL PROPAGATION AND MULTIPLICATION MEDIUM AND METHOD |
PCT/FR1999/000578 WO1999047648A2 (en) | 1998-03-13 | 1999-03-15 | Medium and method for viral propagation and growth |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0101081A2 true HUP0101081A2 (en) | 2001-07-30 |
HUP0101081A3 HUP0101081A3 (en) | 2003-04-28 |
Family
ID=9524203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0101081A HUP0101081A3 (en) | 1998-03-13 | 1999-03-15 | Medium and method for viral propagation and growth |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1062324A2 (en) |
JP (1) | JP2002506636A (en) |
KR (1) | KR20010072556A (en) |
CN (1) | CN1301297A (en) |
AU (1) | AU752577B2 (en) |
BR (1) | BR9908744A (en) |
CA (1) | CA2322619A1 (en) |
EA (1) | EA200000934A1 (en) |
FR (1) | FR2775983B1 (en) |
HU (1) | HUP0101081A3 (en) |
IL (1) | IL138250A0 (en) |
NZ (1) | NZ506872A (en) |
PL (1) | PL343557A1 (en) |
SK (1) | SK12882000A3 (en) |
TR (1) | TR200002641T2 (en) |
WO (1) | WO1999047648A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (en) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | Japanese encephalitis virus vaccine |
AT409379B (en) * | 1999-06-02 | 2002-07-25 | Baxter Ag | MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE |
CA2441688C (en) * | 2001-03-27 | 2014-01-21 | Vertex Pharmaceuticals Incorporated | Compositions and methods useful for hcv infection |
DK2287288T3 (en) * | 2002-07-09 | 2013-01-07 | Baxter Int | Medium free of animal protein for cell culture |
GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
DK2522717T3 (en) | 2006-01-04 | 2014-04-22 | Baxter Int | Oligopeptide-free cell culture media |
JP5458536B2 (en) * | 2008-09-17 | 2014-04-02 | 不二製油株式会社 | Method for producing lactic acid and additive for lactic acid fermentation |
CN107043739A (en) * | 2017-04-24 | 2017-08-15 | 浙江美保龙生物技术有限公司 | A kind of Vero cell culture solution additive and preparation method thereof, application method |
CN107129963A (en) * | 2017-04-24 | 2017-09-05 | 浙江美保龙生物技术有限公司 | A kind of cell culture solution additives of DF 1 and preparation method thereof, application method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498537A (en) * | 1994-03-09 | 1996-03-12 | Cellco, Inc. | Serum-free production of packaged viral vector |
FR2732347A1 (en) * | 1995-03-30 | 1996-10-04 | Bio Media | Plant extract used as cell growth factor medicament with antitumoural and anticancer activity |
EP0912191B1 (en) * | 1997-04-16 | 2003-04-09 | Feva N.V. | Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
-
1998
- 1998-03-13 FR FR9803333A patent/FR2775983B1/en not_active Expired - Fee Related
-
1999
- 1999-03-15 CN CN99803965A patent/CN1301297A/en active Pending
- 1999-03-15 HU HU0101081A patent/HUP0101081A3/en unknown
- 1999-03-15 AU AU27352/99A patent/AU752577B2/en not_active Ceased
- 1999-03-15 SK SK1288-2000A patent/SK12882000A3/en unknown
- 1999-03-15 TR TR200002641T patent/TR200002641T2/en unknown
- 1999-03-15 BR BR9908744A patent/BR9908744A/en not_active IP Right Cessation
- 1999-03-15 NZ NZ506872A patent/NZ506872A/en unknown
- 1999-03-15 EP EP99907713A patent/EP1062324A2/en not_active Withdrawn
- 1999-03-15 JP JP2000536831A patent/JP2002506636A/en not_active Withdrawn
- 1999-03-15 CA CA 2322619 patent/CA2322619A1/en not_active Abandoned
- 1999-03-15 KR KR1020007010026A patent/KR20010072556A/en not_active Application Discontinuation
- 1999-03-15 EA EA200000934A patent/EA200000934A1/en unknown
- 1999-03-15 IL IL13825099A patent/IL138250A0/en unknown
- 1999-03-15 PL PL34355799A patent/PL343557A1/en not_active Application Discontinuation
- 1999-03-15 WO PCT/FR1999/000578 patent/WO1999047648A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999047648A2 (en) | 1999-09-23 |
EA200000934A1 (en) | 2001-02-26 |
PL343557A1 (en) | 2001-08-27 |
CA2322619A1 (en) | 1999-09-23 |
CN1301297A (en) | 2001-06-27 |
HUP0101081A3 (en) | 2003-04-28 |
JP2002506636A (en) | 2002-03-05 |
AU752577B2 (en) | 2002-09-26 |
WO1999047648A3 (en) | 1999-11-04 |
IL138250A0 (en) | 2001-10-31 |
EP1062324A2 (en) | 2000-12-27 |
SK12882000A3 (en) | 2001-05-10 |
NZ506872A (en) | 2002-03-01 |
TR200002641T2 (en) | 2000-11-21 |
KR20010072556A (en) | 2001-07-31 |
FR2775983A1 (en) | 1999-09-17 |
AU2735299A (en) | 1999-10-11 |
BR9908744A (en) | 2000-12-26 |
FR2775983B1 (en) | 2000-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200200604A1 (en) | PRODUCTION VACCINES | |
DK0983342T3 (en) | Culture medium with soybean extract as amino acid source and no animal complexes of animal origin | |
MXPA05009096A (en) | Animal-free cell culture method. | |
HK1019233A1 (en) | Animal cells and processes for the replication of influenza viruses | |
HK1108713A1 (en) | Animal protein free media for cultivation of cells | |
ATE289348T1 (en) | METHODS OF INCREASE VIRAL VACCINE PRODUCTION IN CELL CULTURE BY SUPPRESSING INTERFERON | |
WO1999057246A8 (en) | Animal cell culture media comprising non-animal or plant-derived nutrients | |
AU4751697A (en) | Animal cell culture media comprising plant-derived nutrients | |
CA2494379A1 (en) | Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions | |
HUP0101081A2 (en) | Medium and method for viral propagation and growth | |
DE60218327D1 (en) | INACTIVATED IMMUNOGENIC BACTERIAL ALL-CELL COMPOSITIONS | |
HU9202009D0 (en) | Matrix with adherently bound cells and method for producing viruses and antigens thereof | |
DE60038045D1 (en) | NON-PATHOGEN KINETOPLASTIDE PROTEIN EXPRESSION SYSTEM | |
JPS6485092A (en) | Production of protein | |
CA2250714A1 (en) | Animal cells and processes for the replication of influenza viruses |